Applications

PROTAC Discovery

E3 ligands, ligand-linkers, PEG and alkyl linkers, click handles, and bifunctional degrader intermediate support.

How this supports a project

A PROTAC design must define the target-binding ligand, E3-recruiting ligand, both attachment points, and linker as one testable molecule. Supplying any one component does not establish target degradation.

Design the whole ternary-complex system

A conventional bifunctional PROTAC contains a target-protein ligand, an E3-ligase ligand, and a linker. The attachment point on each ligand is part of the design because it changes how the two proteins and the degrader can form a ternary complex.

Linker selection cannot be reduced to length. Composition, rigidity, polarity, and both exit vectors affect accessible conformations, physicochemical properties, target engagement, and ternary-complex geometry. A linker or E3 ligand that works in one published degrader is therefore a starting point for a new series, not a transferable performance claim.

How material decisions enter the program

1

Define the target-binding ligand

Provide the exact ligand or reference structure, confirmed binding mode when available, tolerated attachment position, and functional group constraints.

2

Select the E3-ligase ligand

Identify the E3 system, ligand scaffold, stereochemistry, protected form, and a literature-supported or experimentally justified exit vector.

3

Plan a linker series

Vary length, PEG or alkyl content, rigidity, polarity, branching, and connection chemistry in a controlled matrix rather than selecting one linker by convention.

4

Prepare and characterize compounds

Confirm structure, stereochemistry where relevant, identity, purity, residual reagents, solubility handling, and storage conditions for each bifunctional molecule.

5

Test molecular engagement

Measure target and E3 binding as appropriate and evaluate ternary-complex formation or cooperativity with methods suited to the system.

6

Confirm degradation mechanism

Establish concentration and time dependence, target loss, proteasome and E3 dependence, selectivity, and functional response with matched controls.

What to define before an inquiry

Target ligand

Exact identity or structure, binding data, attachment position, and groups that must remain unmodified.

E3-ligase system

E3 identity, ligand class, stereochemical requirement, attachment point, and any protected-intermediate preference.

Linker design space

Length range, composition, rigidity, polarity, cleavability if relevant, terminal handles, and acceptable molecular-property limits.

Synthesis plan

Preferred coupling order, protected intermediates, scale, purity target, analytical methods, and material form.

Biological test plan

Cell or biochemical system, target-engagement and degradation assays, time points, controls, and selectivity measurements.

Application boundary

This page covers E3-ligase ligand derivatives, ligand-linker intermediates, PEG or alkyl linkers, reactive handles, and custom bifunctional intermediates. It does not imply target binding, ternary-complex formation, degradation, cellular activity, selectivity, efficacy, safety, clinical suitability, or regulatory status. Those outcomes require testing of the complete molecule in the intended system.

Related catalog and technical pages

Sources

  1. 1.Catalytic in vivo protein knockdown by small-molecule PROTACs (Nature Chemical Biology, 2015)
  2. 2.Structural basis of PROTAC cooperative recognition for selective protein degradation (Nature Chemical Biology, 2017)
  3. 3.E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment Points (Frontiers in Chemistry, 2021)
  4. 4.Rationalizing PROTAC-Mediated Ternary Complex Formation Using Rosetta (Journal of Chemical Information and Modeling, 2021)